Komori
Monstarlab (5255) · RiskMaterialised

Share Dilution Through Stock Acquisition Rights

First written in FY2022. 5 of 6 entries say "Materialised", first in FY2023-Q3. Latest entry: 2026-02-27.

6entries
4years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2022MaterialisedFY2023-Q3 – 2026-02-272023: 220232024: 120242025: 220252026: 12026
Same theme, other companies
Share Dilution from Issuance of Additional Shares and Stock Acquisition RightsA theme 95 companies write about · 95 as a headwind · 0 as a tailwind

Monstarlab moved to the "Worse" side of this theme in 2023, 2 years after the typical company in this theme (2021).

The whole theme swung hardest in 2017: 17 of 34 companies on the "Worse" side.

44 other companies' latest entry also says "Materialised".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 95 companies compared. The sentences above are computed from all 95.
Full recordFilings, disclosures and news, newest first
  1. 2026-02-27MaterialisedEarnings

    「During the consolidated accounting period from 1 January 2025 to 31 December 2025, we raised ¥2,843,084 thousand through the exercise of the 81st series of stock acquisition rights with an exercise price adjustment clause. All of these stock acquisition rights had been exercised by 23 June 2025.」

    The disclosure stated that all of the 81st series of stock acquisition rights had been exercised and that ¥2,843,084 thousand had been raised.
  2. FY2025-H1MaterialisedAnnual report

    「Number of bonds with stock acquisition rights subject to exercise-price adjustment exercised during the interim accounting period 251,500 Number of shares delivered upon exercise during the interim accounting period 25,150,000 Amount raised through exercises during the interim accounting period (¥ million) 2,843 Cumulative number of shares delivered upon exercise as of the end of the interim accounting period 30,000,000 Cumulative amount raised through exercises as of the end of the interim accounting period (¥ million) 3,346」

    Exercise of the 81st Stock Acquisition Rights resulted in the issuance of 25.15 million shares and raised ¥2,843 million during the interim period. Cumulatively, 30 million shares had been issued and ¥3,346 million raised, representing substantial dilution through share issuance.
  3. FY2024MaterialisedAnnual report

    「Number of bonds with stock acquisition rights subject to exercise-price adjustment exercised during the period 48,500 Number of shares delivered upon exercise during the period 4,850,000 Amount raised through exercises during the period (¥ million) 503」

    Exercise of the 81st Stock Acquisition Rights resulted in the issuance of 4,850,000 shares and raised ¥503 million from October through December 2024. Dilution through stock acquisition rights materialized as a large share issuance.
  4. FY2023MaterialisedAnnual report

    「As of the end of December 2023, the number of potential shares from stock acquisition rights was 3,327,500, equivalent to 9.69% of the 34,326,950 issued shares.」

    A total of 46,000 shares were issued through the exercise of stock acquisition rights during 2023. At year-end, potential shares totaled 3,327,500, or 9.69% of issued shares.
  5. FY2023-Q3MaterialisedAnnual report

    「Between 1 October 2023 and 31 October 2023, the number of issued shares increased by 46,000 through the exercise of stock acquisition rights.」

    The exercise of stock acquisition rights increased issued shares by 46,000 during October 2023, realizing the potential-share dilution risk through an actual share issuance.
  6. FY2022First statedAnnual report

    「As of the end of December 2022, the number of potential shares from stock acquisition rights was 74,000, equivalent to 11.7% of the 634,039 issued shares.」

    The exercise of stock options could dilute existing shareholders’ share value. Potential shares represented 11.7% of issued shares.
Moved together

"Legal, Foreign Exchange and Labor Cost Risks Associated with Overseas Expansion" moved the same way as this thread, in the same document, in 4 of its 6 moves.

433222★123456
  1. ★This thread
  2. 1Legal, Foreign Exchange and Labor Cost Risks Associated with Overseas Expansion4×
  3. 2Sales Growth While Maintaining a High Gross Margin and Improving Profitability3×
  4. 3Improving Operating and Net Profit Margins After Upfront Investment3×
  5. 4Growing Existing-Customer Revenue by Cultivating Major Accounts2×
  6. 5Global expansion into 20 countries and regions and 33 cities2×
  7. 6Expanding the high-value customer base through sales-enhancing digital transformation2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Monstarlab yet. It last moved in the Earnings of 2026-02-27: "Materialised".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Share Dilution Through Stock Acquisition Rights | Monstarlab Inc. (5255) | Komori